Abstract
3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3 H)-one (3BDO) is a mTOR agonist that inhibits autophagy. The main purpose of this study is to investigate the effects of 3BDO on seizure and cognitive function by autophagy regulation in pentylenetetrazol (PTZ)-kindled epileptic mice model. The PTZ-kindled epileptic mice model was used in study. The behavioral changes and electroencephalogram (EEG) of the mice in each group were observed. The cognitive functions were tested by Morris water maze test. The loss of hippocampal neurons was detected by hematoxylin-eosin (HE) staining and immunofluorescence analysis. Immunohistochemistry, western blot and q-PCR were employed to detect the expression of autophagy-related proteins and mTOR in the hippocampus and cortex. Less seizures, increased hippocampal neurons and reduced astrocytes of hippocampus were observed in the 3BDO-treated epileptic mice than in the PTZ-kindled epileptic mice. Morris water maze test results showed that 3BDO significantly improved the cognitive function of the PTZ-kindled epileptic mice. Western blot analyses and q-PCR revealed that 3BDO inhibited the expression of LC3, Beclin-1, Atg5, Atg7 and p-ULK1/ULK1, but increased that of p-mTOR/mTOR, p-P70S6K/P70S6K in the hippocampus and temporal lobe cortex of epileptic mice. Immunohistochemistry and immunofluorescence also showed 3BDO inhibited the LC3 expression and increased the mTOR expression in the hippocampus of epileptic mice. In addition, the autophagy activator EN6 reversed the decrease in the 3BDO-induced autophagy and aggravated the seizures and cognitive dysfunction in the epileptic mice. 3BDO regulates autophagy by activating the mTOR signaling pathway in PTZ-kindled epileptic mice model, thereby alleviating hippocampus neuronal loss and astrocytes proliferation, reducing seizures and effectively improving cognitive function. Therefore, 3BDO may have potential value in the treatment of epilepsy.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Chen S, Chen Y, Zhang Y, Kuang X, Liu Y, Guo M, Ma L, Zhang D, Li Q (2020) Iron metabolism and ferroptosis in epilepsy. FrontNeurosci 14:601193
Muhlhofer W, Tan Y, Mueller S, Knowlton R (2017) MRI-negative temporal lobe epilepsy-What do we know? Epilepsia 58:727–742
Thom M (2014) Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol 40:520–543
Malmgren K, Thom M (2012) Hippocampal sclerosis–origins and imaging. Epilepsia. 53:19–33. https://doi.org/10.1111/j.1528-1167.2012.03610.x
Thijs R, Surges R, O’Brien T, Sander J (2019) Epilepsy in adults. Lancet (London England) 393:689–701
Moshé S, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet (London England) 385:884–898
Kaur J, Famta P, Famta M, Mehta M, Satija S, Sharma N, Vyas M, Khatik G, Chellappan D, Dua K, Khurana N (2021) Potential anti-epileptic phytoconstituents: An updated review. J Ethnopharmacol 268:113565
Bortz J (2003) Neuropsychiatric and memory issues in epilepsy. Mayo Clinic Proceedings 78:781–787
Gan J, Qu Y, Li J, Zhao F, Mu D (2015) An evaluation of the links between microRNA, autophagy, and epilepsy. Rev Neurosci 26:225–237
Giorgi F, Biagioni F, Lenzi P, Frati A, Fornai F (2015) The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations. J Neural Transm 122:849–862
Kaushik S, Tasset I, Arias E, Pampliega O, Wong E, Martinez-Vicente M, Cuervo A (2021) Autophagy and the hallmarks of aging. Ageing Res Rev 72:101468
Pondrelli F, Muccioli L, Licchetta L, Mostacci B, Zenesini C, Tinuper P, Vignatelli L, Bisulli F (2021) Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis. Orphanet J Rare Dis 16:362
Marsan E, Baulac S (2018) Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 44:6–17
Lu D, Karas P, Krueger D, Weiner H (2018) Central nervous system manifestations of tuberous sclerosis complex. Am J Med Genet C 178:291–298
Dong Y, Wang S, Zhang T, Zhao X, Liu X, Cao L, Chi Z (2013) Ascorbic acid ameliorates seizures and brain damage in rats through inhibiting autophagy. Brain Res 1535:115–123
Rami A, Benz A, Niquet J, Langhagen A (2016) Axonal accumulation of lysosomal-associated membrane protein 1 (LAMP1) Accompanying alterations of autophagy dynamics in the rat hippocampus upon seizure-induced injury. Neurochem Res 41:53–63
Şentürk M, Lin G, Zuo Z, Mao D, Watson E, Mikos A, Bellen H (2019) Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol 21:384–396
Brugarolas J, Lei K, Hurley R, Manning B, Reiling J, Hafen E, Witters L, Ellisen L, Kaelin W (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18:2893–2904
Sax J, Dash B, Hong R, Dicker D, El-Deiry W (2002) The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression). Cell Cycle (Georgetown, Tex). 1:90–96
Wang W, Liu X, Zhang Y, Zhao J, Zhao B, Zhang S, Miao J (2007) Both senescence and apoptosis induced by deprivation of growth factors were inhibited by a novel butyrolactone derivative through depressing integrin beta4 in vascular endothelial cells. Endothelium 14:325–332
Lin C, Fang J, Xiang Q, Zhou R, Yang L (2021) Exendin-4 promotes autophagy to relieve lipid deposition in a NAFLD cell model by activating AKT/mTOR signaling pathway. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 41:1073–1078
Liang Q, Dong W, Ou M, Li Z, Liu C, Wang F, Liu Y, Wang W (2021) Penaeus vannameimiR-151 affects low-temperature tolerance of by modulating autophagy under low-temperature stress. Front Cell Dev Biol 9:595108
Peng N, Meng N, Wang S, Zhao F, Zhao J, Su L, Zhang S, Zhang Y, Zhao B, Miao J (2014) An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E−/− mice. Sci Rep 4:5519
Wei L, Yang H, Xie Z, Yang S, Yang H, Zhao C, Wang P, Xu S, Miao J, Zhao B, Bi J (2012) A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model. J Alzheimer’s Dis 30:531–543
Racine R (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294
Biggane J, Xu K, Goldenstein B, Davis K, Luger E, Davis B, Jurgens C, Perez D, Porter J, Doze V (2022) Pharmacological characterization of the α-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency. J Recept Signal Transduct Res. https://doi.org/10.1080/10799893.2022.2110896
Hu A, Yuan H, Qin Y, Zhu Y, Zhang L, Chen Q, Wu L (2022) Lipopolysaccharide (LPS) increases susceptibility to epilepsy via interleukin-1 type 1 receptor signaling. Brain Res 1793:148052
Chung C, Shin H, Berdan C, Ford B, Ward C, Olzmann J, Zoncu R, Nomura D (2019) Covalent targeting of the vacuolar H-ATPase activates autophagy via mTORC1 inhibition. Nat Chem Biol 15:776–785
Singh T, Mishra A, Goel R (2021) PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis. https://doi.org/10.1007/s11011-021-00823-3
Zhao X, Su L, He X, Zhao B, Miao J (2020) CA7-4Long noncoding RNA promotes autophagy and apoptosis via sponging and in high glucose-induced vascular endothelial cells. Autophagy 16:70–85
Meng N, Zhao J, Su L, Zhao B, Zhang Y, Zhang S, Miao J (2012) A butyrolactone derivative suppressed lipopolysaccharide-induced autophagic injury through inhibiting the autoregulatory loop of p8 and p53 in vascular endothelial cells. Int J Biochem Cell Biol 44:311–319
Huang B, Meng N, Zhao B, Zhao J, Zhang Y, Zhang S, Miao J (2009) Protective effects of a synthesized butyrolactone derivative against chloroquine-induced autophagic vesicle accumulation and the disturbance of mitochondrial membrane potential and Na+, K+- ATPase activity in vascular endothelial cells. Chem Res Toxicol 22:471–475
Yang S, Wang S, Peng N, Xie Z, Wang P, Zhao C, Wei L, Yang H, Zhao B, Miao J, Bi J (2012) Butyrolactone derivative 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one protects against amyloid-β peptides-induced cytotoxicity in PC12 cells. J Alzheimer’s Dis 28:345–356
Funding
This study was supported by grants from the Natural Science Foundation of Hainan Province (819QN370 and 819QN367), the National Natural Science Foundation of China (81760244, 81960249 and 82260270), Hainan Provincial Key Research and Development Plan of China (ZDYF2019124 and ZDYF2022SHFZ109), Epilepsy Research Science Innovation Group of Hainan Medical University (2022), Hainan Province Clinical Medical Center (2021) and the Excellent Talent Team of Hainan Province (No. QRCBT202121).
Author information
Authors and Affiliations
Contributions
MG conceived the experimental design, performed the project research, and participated in the experimental process. MG and SC searched the available literature, sorted the references, and wrote this manuscript. JL and HC were involved in the literature search. QL and DJ coordinated and supervised the study, provided research direction, designed the research strategy, and modified the final draft. All authors have carefully read and confirmed the final version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no potential conflict of interest. We confirm that we have read the Journal’s position on potential ethical issues involved in the publication and confirm compliance with those guidelines.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Guo, M., Chen, S., Lao, J. et al. 3BDO Alleviates Seizures and Improves Cognitive Function by Regulating Autophagy in Pentylenetetrazol (PTZ)-Kindled Epileptic Mice Model. Neurochem Res 47, 3777–3791 (2022). https://doi.org/10.1007/s11064-022-03778-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-022-03778-8